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Ethnic-speciﬁc associations of rare and
low-frequency DNA sequence variants with asthma
Catherine Igartua1, Rachel A. Myers1, Rasika A. Mathias2, Maria Pino-Yanes3,4, Celeste Eng3, Penelope E. Graves5,
Albert M. Levin6, Blanca E. Del-Rio-Navarro7, Daniel J. Jackson8, Oren E. Livne1, Nicholas Rafaels9,
Christopher K. Edlund10, James J. Yang11, Scott Huntsman3, Muhammad T. Salam10, Isabelle Romieu12,
Raphael Mourad1, James E. Gern8,13, Robert F. Lemanske8,14, Annah Wyss15, Jane A. Hoppin15,16,
Kathleen C. Barnes2, Esteban G. Burchard3,17, W. James Gauderman10, Fernando D. Martinez5,
Benjamin A. Raby18,19, Scott T. Weiss18, L. Keoki Williams20,21, Stephanie J. London15, Frank D. Gilliland10,
Dan L. Nicolae1,22 & Carole Ober1
Common variants at many loci have been robustly associated with asthma but explain little of
the overall genetic risk. Here we investigate the role of rare (o1%) and low-frequency (1–5%)
variants using the Illumina HumanExome BeadChip array in 4,794 asthma cases, 4,707 non-
asthmatic controls and 590 case–parent trios representing European Americans, African
Americans/African Caribbeans and Latinos. Our study reveals one low-frequency missense
mutation in the GRASP gene that is associated with asthma in the Latino sample (P¼4.31
 106; OR¼ 1.25; MAF¼ 1.21%) and two genes harbouring functional variants that are
associated with asthma in a gene-based analysis: GSDMB at the 17q12–21 asthma locus in the
Latino and combined samples (P¼ 7.81 108 and 4.09 108, respectively) and MTHFR
in the African ancestry sample (P¼ 1.72 106). Our results suggest that associations with
rare and low-frequency variants are ethnic speciﬁc and not likely to explain a signiﬁcant
proportion of the ‘missing heritability’ of asthma.
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A
sthma is a common, chronic inﬂammatory disease of the
airways with typical onset in childhood. Heritability
estimates indicate that approximately half the variation
in risk is attributable to genetic factors1–3; yet, the common
variants identiﬁed by genome-wide association studies (GWAS)
account for very little of the genetic risk4–7. This so-called
‘missing heritability’ in asthma and other common diseases has
been attributed to many potential causes that generally fall into
two categories8. First, the genetic variants interrogated by GWAS
may not capture all relevant variation. In particular, rare variants,
which comprise the bulk of genetic variation in the human
genome and are predicted to have larger phenotypic effects than
common variants, are not represented or tagged by the single-
nucleotide polymorphisms (SNPs) that are included on the
genotyping arrays typically used in GWAS. Second, the statistical
approaches used in GWAS may be overly simplistic and not
adequately model the genetic architecture of asthma, which is
probably polygenic and includes many gene–environment
interactions9.
In this study, we begin to address the ﬁrst limitation of GWAS
by investigating the role of rare (minor allele frequency (MAF)
o1%) and low-frequency (MAF 1–5%) variants in asthma. We
conducted this meta-analysis study in the largest ethnically
diverse sample of asthma cases, non-asthmatic controls and case–
parent trios, which include 13 studies4,10,11 from 8 groups of
investigators who compose the EVE Consortium on Asthma
Genetics4,10. We conducted analyses separately in each of the 13
study samples and used meta-analyses to ﬁrst combine results
within each of three major ethnic/racial groups (European
American, African American/African Caribbean and Latino)
and then across all ethnic/racial groups to yield measures of
association for the combined sample. Here we report associations
with a low-frequency functional variant and lower risk for asthma
in Latinos in a novel gene, GRASP, and with functional variants in
the MTHFR gene in an African ancestry sample. We also report
an association in Latinos and in the combined sample with
functional variants in GSDMB, a gene at the 17q12–21 asthma
locus4,5,12–14, which is attributed to a putatively damaging
common missense mutation.
Results
Single-variant association analyses. We ﬁrst evaluated the
individual effects of low-frequency, putatively functional exonic
variants on asthma risk in 11,225 subjects representing European
Americans, African Americans, African Caribbeans, Mexican
Americans, Mexicans and Puerto Ricans (Table 1). We tested
each low-frequency variant, deﬁned as having a MAF between 1%
and 5% within each ethnic group. For the meta-analysis in the
combined sample, we excluded variants that were either common
(MAFZ5%) in all three ethnic groups or rare (o1%) in all three
ethnic groups (Supplementary Table 1 and Supplementary
Table 2). This deﬁnition allows us to include SNPs that may be
common in one population but rare in the other(s). The quantile–
quantile plots for the analyses of low-frequency variants indicated
that there was no inﬂation of test statistics (Supplementary
Fig. 1). One missense mutation (c.C1093G, p.L365V) in the
GRASP gene was associated with asthma risk in the Latinos after
correcting for multiple testing (9,519 tests; Genome-wide Efﬁcient
Mixed Model Association (GEMMA)15/Family Based Association
Table 1 | Sample composition.
Sample Case Control Male Female Total
European American
ALHS 776 802 859 719 1,578
CAG 186 209 172 223 395
CAMP* 376 706 588 494 1,082
CHS 415 640 546 509 1,055
COAST 134 119 150 103 253
Total 1,511
376*
1,770 2,315 2,048 4,363
African Ancestry
CAG 274 200 170 304 474
GRADD-AA 236 288 199 325 524
GRADD-ACw 227 297 250 274 524
SAPPHIRE 553 233 278 508 786
Total 1,290 1,018 897 1,411 2,308
Latino
CHS 581 775 713 643 1,356
GALA II-MA 568 604 568 604 1,172
GALA II-PR 844 540 731 653 1,384
MCAAS* 214 428 337 305 642
Total 1,993
214*
1,919 2,349 2,205 4,554
Combined
Total 4,794
590*
4,707 5,561 5,664 11,225
ALHS, Agricultural Lung Heath Study; CAG, Chicago Asthma Genetics Study; CAMP, Childhood Asthma Management Program; CHS, The Children’s Health Study; COAST, The Childhood Origins of
Asthma Study; GALA II, Genes–Environment and Admixture in Latino Asthmatics (-MA, Mexican American; -PR, Puerto Rican); GRAAD, Genomic Research on Asthma in the African Diaspora and
Barbados (-AA, African Americans; -AC, African Caribbeans); MCCAS, Mexico City Childhood Asthma Study; SAPPHIRE, The Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-
Ethnicity.
Descriptions of the individual study samples have either been published4,10 or are described in Supplementary Note 1.
*Case–parent trios.
wSamples from 154 families; kinship matrix was used to address family structure as implemented in GEMMA15.
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Test (FBAT)16 meta-analysis, P¼ 4.31 10 6; N¼ 4,554; odds
ratio (OR)¼ 1.25; MAF¼ 0.012). Six additional low-frequency
variants were modestly associated at suggestive levels of
signiﬁcance (Po10 4) in at least one of the three groups or in
the combined sample (Table 2). Of these, ﬁve missense mutations
(one each in FAM134B, NPC1L1, IKZF1, SLC26A3 and GSDMB)
showed evidence of association with asthma in the combined
sample, two of which (IKZF1 and SLC26A3) were more
signiﬁcant in the African ancestry sample. The low-frequency
variants at FAM134B (c.G1145C, p.S382T; transcript accession
NM_001034850), NPC1L1 (c.C2920T, p.P974S) and IKZF1
(c.G1009A, p.G337S; transcript accession NM_006060) were all
associated with lower risk for asthma, whereas the variants in
SLC26A3 (c.A241G, p.I81V) and GSDMB (c.A365G, p.E122G;
transcript accession NM_001042471) were associated with
increased risk for asthma. An additional nonsense mutation
(c.C919T, p.R307X) in PDE4DIP was also associated with asthma
risk in the African ancestry sample. The latter result is
noteworthy for two reasons. First, an exome-sequencing study
in a European American, non-Hispanic white nuclear family with
two asthmatic and two non-asthmatic children also reported a
missense mutation in PDE4DIP (c.A907C, p.I303L) segregating
with asthma17. Second, this gene encodes a protein that interacts
with PDE4D, a gene that was identiﬁed in a GWAS of asthma18.
Our results further implicate this pathway in asthma
pathogenesis.
The missense mutation in GSDMB is also intriguing, because
this gene is at the well-replicated 17q12–21 asthma locus4,5; this
signal is largely attributable to the GALA II Mexican American
sample (GEMMA, P¼ 1.1 10 4; N¼ 1,172). This variant
showed striking MAF differences between the groups, ranging
from 0.19 in the Latinos to 0.0031 in the African Americans and
0.0023 in the European Americans, but was included because it
was neither rare nor common in all three groups (see Methods).
Conditional analyses at the 17q12–21 locus. To determine
whether the association with this variant (c.A365G, p.E122G;
rs12450091) in Latinos and the combined sample represents
independent risk for asthma or is in linkage disequilibrium (LD)
with the common variants at the 17q12–21 locus that have been
associated with asthma in previous GWAS4,5,19,20, we performed
conditional analyses of rs12450091 in the case–control samples
only (case–parent trio studies were excluded and meta P-value
recalculated: Latino GEMMA meta-analysis P¼ 6.89 10 5,
N¼ 3,912; combined GEMMA meta-analysis P¼ 5.52 10 5,
N¼ 9,501). For this analysis, we ﬁrst identiﬁed three common
variants (one synonymous, one missense and one intronic) at this
locus that were included on the exome array and associated with
asthma in previous reports (G at rs907092 (refs 4,5,19), G at
rs2305480 (refs 5,20) and T at rs7216389 (refs 5,21,22)). In
Latinos, the risk allele at rs12450091 (C) tags 28% of the high-risk
GGT haplotypes (GGCT frequency 18.09%, GGTT frequency
45.84%) and is not in LD with any of the known expression
quantitative trait loci reported at this locus12,21–24. We then
repeated the association studies with rs12450091 (c.A365G,
p.E122G) in GSDMB in three separate analyses, including each
of the common variants as a covariate in each analysis to ‘remove’
the effects of the common variant on the association signal. In
each of these three analyses, the evidence for association between
rs12450091 and asthma was reduced from P¼ 6.89 10 5 to
Pr0.022 in Latinos and from P¼ 5.52 10 5 to Pr0.019 in the
combined sample (Table 3). These results suggest that although
most of the evidence for association with this variant was shared
with the associated common variants, the residual signal in
conditional analyses indicates that this missense substitution or a
variant in strong LD with the missense substitution contributes
additional, independent risk to asthma in Latinos.
Power analyses for low-frequency variants. After testing for
nearly 33,000 functional low-frequency exonic variants in 11,225
subjects, only 1 variant remained statistically signiﬁcant in Lati-
nos after correcting for testing of 9,519 of variants and only 6
were modestly associated at P-values o10 4 in the African
ancestry or the combined sample. To assess whether the paucity
of associations was due to lack of power, we performed simula-
tions to determine the power of our studies to detect associations
with asthma for low-frequency variants. We considered ORs of
1.5, 2, 2.5, 3 and 4, within the expected ranges of effect sizes for
Table 2 | Results of meta-analyses of single SNP association studies of low-frequency functional variants and asthma risk with
association P-values o104.
GEMMA/FBAT meta-analysis P-values MAF OR (95% CI)
rsID
(Chr: position)
Gene Residue
change
Alleles COMB
(N¼ 11,225)
EA
(N¼4,363)
AA
(N¼ 2,308)
LAT
(N¼4,554)
EA AA LAT COMB EA AA LAT
rs141783558
(1:144930790)
PDE4DIP c.C919T,
p.R307X
T/C 1.48 10 3 — 9.76 10 5 — 1.22 104 0.0313 3.41 10 3 1.12
(1.04–1.21)
— 1.17
(1.08–1.26)
—
rs61733811
(5:16475199)
FAM134B c.G1145C,
p.S382T
(NM_0010
34850)
G/C 1.30 10 5 — — 6.56 10 3 7.30 104 0.1175 0.0146 0.92
(0.89–0.95)
— — 0.89
(0.81–0.97)
rs149782907
(7:44561344)
NPC1L1 c.C2920T,
p.P974S
T/C 2.66 10 5 — 1.13 104 — 7.30 104 0.0142 1.28 10 3 0.8
(0.72–0.89)
— 0.8
(0.71–0.89)
—
rs148169768
(7:50467774)
IKZF1 c.G1009A,
p.G337S
(NM_00
6060)
A/G 6.55 10 5 — 1.68 10 5 — 0 0.0109 5.33 104 0.77
(0.68–0.87)
— 0.74
(0.65–
0.85)
—
rs116793431
(7:107434217)
SLC26A3 c.A241G,
p.I81V
G/A 7.89 10 5 — 4.97 10 5 — 4.87 104 0.0475 4.15 10 3 1.12
(1.06–1.19)
— 1.14
(1.07–1.21)
—
rs7974426
(12:52408888)
GRASP c.C1093G,
p.L365V
G/C 0.0543 0.99 — 4.31 106 0.0337 0.0059 0.0121 1.04
(0.99–1.10)
0.98
(0.91–1.04)
— 1.25
(1.14–1.38)
rs12450091
(17:38068621)
GSDMB c.A365G,
p.E122G
(NM_00
1042471)
G/A 5.56 10 5 — — — 2.31 10 3 3.11 10 3 0.1945 1.07
(1.03–1.1)
— — —
AA, African Ancestry; Chr, chromosome; CI, conﬁdence interval; COMB, combined; EA, European American; LAT, Latino; MAF, minor allele frequency; OR, odds ratio.
Positions are from NCBI build 37. For residue changes, the transcript accession number is presented in parenthesis when multiple transcripts exist. Alleles are presented as minor allele/major allele.
Ethnic speciﬁc meta-analyses were performed for all low-frequency variants (MAF 1–5%; 8,249 in European American, 17,861 in African American and 9,519 in Latinos); the combined meta-analysis
included variants that were neither common (Z5%) nor rare (o1%) in all three ethnic groups (32,681 variants). ORs are calculated for case–control studies only (case–parent trio studies excluded) and
presented for the minor allele. Only the association with the GRASP variant in Latinos was signiﬁcant after Bonferroni correction (9,519 variants, GEMMA/FBAT meta-analysis P¼4.31 106,
N¼4,554). Bold P-values and corresponding ORs represent the meta-analysis associations with P valueso10 4.
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low-frequency variants with moderate-to-high effects. In fact, we
had at least 80% power to detect associations with variants with
frequencies Z1% and ORs Z2.5 in the combined sample. In the
European American and Latino samples, we had 80% power to
detect variants with frequencies Z1% and ORs Z4. We had
lowest power in the African ancestry sample, in which there was
80% power to detect variants with frequencies42% and ORsZ4
(Supplementary Fig. 2). Thus, the lack of signiﬁcant associations
with low-frequency variants in our study could be due to low
power in the ethnic/racial groups, small effect sizes of variants in
this frequency range, or both.
Gene-based analyses. Studies of rare variants have virtually no
power to detect individual associations in samples of even many
thousands of individuals25–27. Rather, gene-based tests that
combine the evidence for association among all variants within
each gene provide more power to detect associations. To test the
hypothesis that the overall burden of functional variants at each
gene confers risk for asthma, we performed a gene-based
association test as implemented in MetaSKAT-O28 for each of
the 10,208 genes represented on the exome array that had three or
more functional variants present in at least two case–control
samples. We included in these analyses all putatively functional
variants on the array regardless of allele frequency. We performed
two sets of analyses. In the ﬁrst we weighted all variants equally,
and in the second we gave larger weights to rarer variants
(MetaSKAT-O default). For each of those analyses, we considered
all potentially functional variants (missense, nonsense and splice
site) and then considered only variants predicted to be ‘probably
damaging’ by Polymorphism Phenotyping v2 (PolyPhen-2)29.
In the analysis with equal weights and deﬁning functional
variants more broadly, associations with GSDMB and ZPBP2,
two genes at the 17q12–21 asthma locus, were signiﬁcant in
the combined (MetaSKAT-O: P¼ 6.10 10 10, 16 variants
and P¼ 1.34 10 6, 7 variants, respectively; N¼ 9,501) and
Latino (MetaSKAT-O: P¼ 1.02 10 6, 12 variants and
P¼ 1.73 10 6, 7 variants, respectively; N¼ 3,912) samples
after Bonferroni correction for 9,534 and 10,439 genes,
respectively. In addition, the MTHFR gene was signiﬁcant
(MetaSKAT-O: P¼ 1.72 10 6, 11 variants; N¼ 2,308) in the
African ancestry sample after multiple testing correction for
10,342 genes. When we considered only variants with PolyPhen-2
prediction of ‘probably damaging’, the association with GSDMB
remained signiﬁcant (combined MetaSKAT-O: P¼ 4.09 10 8,
7 variants, N¼ 9,501; Latino MetaSKAT-O: P¼ 7.81 10 8,
5 variants, N¼ 3,912), but the associations with the ZBPB2 and
MTHFR genes did not. No genes were signiﬁcant when larger
weights were applied to rare variants in either of the analyses
(Table 4, Supplementary Table 3, Supplementary Figs 3–6),
suggesting that these gene-based associations are driven largely by
the more common functional variants that are present on the
array. In fact, when we remove one common missense SNP in
GSDMB (c.G844A, p.G282R; rs2305479; MAF 0.335 in Latinos),
the evidence for association of this gene in the test that considered
only PolyPhen-2 predicted damaging variants becomes
nonsigniﬁcant (equal weights; MetaSKAT-O P¼ 1.0 in Latinos,
N¼ 3,912 and P¼ 0.276 in the combined sample, N¼ 9,501).
Similar to GSDMB, the associations with ZPBP2 were no longer
signiﬁcant after removing the one common missense variant
(c.G518T p.S173I; rs11557467; MAF 0.3576 in Latinos) and
testing the association of the remaining six variants in the Latino
(MetaSKAT-O: P¼ 0.54, N¼ 3,912) and the combined sample
(MetaSKAT-O: P¼ 0.12, N¼ 9,501). This suggests that the
association with ZPBP2 is driven by this common variant. In
contrast, removing the one common missense variant in MTHFR
(c.C665T p.A222V; rs1801133; MAF¼ 0.11 in African ancestry)
does not eliminate the gene-based association signal (nine rare,
one low-frequency variant; MetaSKAT-O: P¼ 0.002, N¼ 2,308),
indicating that the association with variants in the MTHFR gene
is attributable to common, low-frequency and rare variants.
Assessing coverage of exonic variation on the exome array.
Lastly, we assessed how well the variants on the exome array
captured the low-frequency and rare functional variation present
in the genomes of asthmatic individuals. We had available whole-
genome sequences (WGS) for 278 asthmatics (101 European
Americans, 93 African Americans and 84 Latinos) as part of
ongoing studies of the EVE Consortium4,10, including 172 of the
individuals in this study (43 European Americans, 44 African
Americans and 85 Latinos). We selected all functional exonic
variants with MAFo5% in any of the three groups from the WGS
and compared the overlap between the missense, nonsense and
splice site mutations present in the WGS with the variants on the
exome array. Overall, there were 105,943 rare or low-frequency
variants in 16,359 genes in the WGS of the 278 asthmatic
individuals, of which 65,170 (61.51%) variants in 14,222 genes
(86.93%) were on the array (Table 5). Surprisingly, the proportion
of functional variants on the array was similar in the three ethnic
Table 3 | Conditional analysis results for rs12450091 (c.A365G, p.E122G) in GSDMB after conditioning on 17q12–21 genotypes at
rs7216389, rs2305480, and rs907092.
rsID
(Chr:Position)
Gene Residue Change Alleles GEMMA
meta-analysis P
(COMB)
r2/D0
(LAT)
Conditional GEMMA meta-analysis P for
rs12450091 (c.A365G, p.E122G)
COMB
(no covariate
P¼5.52 10 5)
LAT
(no covariate
P¼6.89 105)
rs907092
(17:37922259)
IKZF3 c.C1314T, p.S438S
(NM_012481)
A/G 2.08 10 10 0.102/0.97 0.0190 0.0215
rs2305480
(17:38062196)
GSDMB c.C892T, p.P298S
(NM_001042471)
T/C 1.09 108 0.104/0.99 0.0139 0.0160
rs7216389
(17:38069949)
GSDMB Intronic C/T 1.23 10 7 0.13/1 0.0131 0.0149
Chr, chromosome; COMB, combined; LAT, Latino.
Three 17q12–21 common variants that were included on the array and associated with asthma in previous GWAS (rs907092, rs2305480, rs7216389) were included as covariates in association studies of
rs12450091 in the case-control samples only (case-parent trio studies excluded and meta P-value recalculated). Conditional analyses included 3,912 subjects for the Latino study and 9,501 for the
combined study. Results for rs12450091 with and without including the common variants are shown. Positions are from NCBI build 37. LD r2 and D’ between rs12450091 and each common variant were
estimated in 4,696 unrelated Latino individuals in our study.
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groups (range: 62.77% to 63.87%), despite the fact that European
Americans were the predominant source of variation in the array
design (B9,000 ofB12,000 subjects)30. Finally, we compared the
number of genes in the WGS with functional exonic variants to
the number of genes represented on the exome array. For this
analysis, we stratiﬁed the 16,359 genes in the WGS with
functional exonic variation into three groups: (i) genes not
represented on the array; (ii) genes represented on the array, but
not all variants are included; and (iii) genes represented on the
array and all functional variants are included. Overall, 2,137 genes
(13.06%) were not represented on the array and those genes
included 5,283 functional exonic variants in the WGS. An
additional 10,686 genes (65.32%) had incomplete sets of
functional variants, with 35,490 variants present in the WGS
but absent on the array. Finally, 3,536 genes (21.61%) had all
9,370 functional exonic variants present in the WGS of asthmatic
individuals (Supplementary Table 4). At the 17q12–21 locus,
ORMDL3 had one rare missense mutation in Latinos (c. C287T,
p.T96M; rs200735199; MAF 0.005) in the WGS and it was not
included on the array, GSDMB had eight variants in the WGS
and seven were on the array (one missense mutation missing,
c.C689T, p.S230F; transcript accession NM_001165959;
rs183724236; MAF 0.005 in African Americans), IKZF3 had
one missense variant in the WGS and it was on the array, and
ZPBP2 had ﬁve variants in the WGS and four were on the array
(one missense mutation missing, c.G586T, pG196C; transcript
accession NM_198844; rs371561983; MAF 0.005 in Latinos).
Thus, overall, the rare and low-frequency functional variation at
the 17q12–21 locus was reasonably well covered by the array.
Discussion
Our study is the largest to date, to assess the effects of rare
variants on asthma risk in ethnically diverse individuals.
Although we were limited by the variation present on the array
and by relatively small samples within each ethnic/racial group,
our results provide several insights into the genetic architecture of
asthma. First, associations with rare or low-frequency variants are
likely to be ethnic speciﬁc. The few signiﬁcant associations that
we detected were all limited to a single ethnic group, despite
having the greatest power to detect associations in the combined
sample. Two novel associations, one with a missense mutation in
the GRASP gene in Latinos and one with the many rare missense
mutations in the MTHFR gene in African Americans/African
Caribbeans, were revealed. The MTHFR gene harbours 11
missense mutations in African Americans, only one of which is
common (rs1801133), and showed a gene-level association with
asthma. Although most mutations in this gene were not predicted
to be ‘damaging’ by PolyPhen-2 scores, the sheer number of
potentially functional variants and the strong association with
asthma in the African ancestry sample makes this gene a good
candidate for further studies. Common variants in MTHFR,
encoding methylenetetrahydrofolate reductase, have been asso-
ciated with many common conditions, including neural tube
defects, vascular disease and pregnancy complications, among
others18,31–33. There have been conﬂicting reports as to whether
the common C677T variant in this gene is associated with asthma
or allergic diseases in European populations4,5,34–36, although
maternal folate levels in pregnancy have been associated with risk
of early asthma outcomes in children37,38. The missense mutation
Table 5 | Functional variant discovery in WGS of 278 asthmatics.
Ethnic group WGS sample size No. functional variants in WGS No. genes with functional variants in WGS
Total Present on exome array (%) Total Present on exome array (%)
European American 101 36,202 22,955 (63.40%) 12,568 10,044 (79.91%)
African Ancestry 93 59,851 38,227 (63.87%) 14,452 12,063 (83.47%)
Latino 84 37,308 23,420 (62.77%) 12,441 9,865 (79.29%)
Combined 278 105,943 65,170 (61.51%) 16,359 14,222 (86.93%)
No, number; WGS, whole genome sequences.
Functional variants in this analysis include all missense, nonsense and splice site mutations with MAFo5% within any of the three ethnic groups. Functional variants in the WGS were excluded if they
were absent in dbSNP137 or in the ESP variant server.
Table 4 | Genes signiﬁcantly associated with asthma.
Sample Gene Chr No. variants MetaSKAT-O P
a. Functional variants: missense, nonsense and splice site
Combined GSDMB 17 16 6.10 10 10
Combined ZPBP2 17 7 1.34 10 6
Latino GSDMB 17 12 1.02 10 6
Latino ZPBP2 17 7 1.73 106
African Ancestry MTHFR 1 11 1.72 10 6
b. Functional variants: PolyPhen-2 probably damaging variants
Combined GSDMB 17 7 4.09 10 8
Latino GSDMB 17 5 7.81 108
Chr, chromosome; No, number.
Gene-based analyses of functional variants were conducted using equal variant weights. All genes with at least 3 functional variants present in at least two studies were included in this analysis. Genes
presented in the table are signiﬁcant after Bonferroni correction for the number of genes tested. Meta-SKAT-O28 gene-based analyses included 3,281 subjects for the European American studies, 2,308
for the African ancestry studies, 3,912 subjects for the Latino studies and 9,501 subjects for the combined studies. a. All missense, nonsense and splice site variants (regardless of MAF) were considered,
resulting in analysis of 8,933 genes in European Americans, 10,342 genes in African Ancestry groups, 10,439 genes in Latinos and 9,534 genes in the combined sample. b. Only variants that are predicted
to be ‘probably damaging’ by PolyPhen-2 (ref. 29) were considered, resulting in analysis of 1,977 genes in European Americans, 2,465 genes in African Ancestry, 2,427 genes in Latinos and 2,316 genes in
the combined sample. Variants included in the gene-based analyses are provided in Supplementary Table 3.
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in GRASP that is associated with asthma in Latinos occurs at a
frequency of 0.012 in this population, at higher frequency (0.034)
in European Americans and very low-frequency (0.006) in the
African ancestry samples. The fact that the association was
conﬁned to Latinos even though we had greater power to detect
associations in the European Americans suggests that the effects
of this variant on asthma risk might involve interactions with
other variants or environmental exposures that are more
common in Latinos, but this single-variant association requires
replication in an independent Latino sample or functional
validation of this variant’s role in asthma risk. GRASP encodes
GRP1 (general receptor for phosphoinositides-1)-associated
scaffold protein and has been shown to be highly expressed in
the brain with lower levels of expression in the lung, heart,
embryo, kidney and ovary39. Although little is known about the
function of this gene or its potential role in asthma, scaffold
proteins have been implicated in asthma signalling pathways40,41.
Second, among the six low-frequency variants showing
suggestive evidence for association with asthma (Table 2), three
variants were associated with decreased risk and three were
associated with increased risk. The discovery of potentially
protective alleles in three genes, FAM134B (family with sequence
similarity 134, member B1), NPC1L1 (Niemann-Pick disease,
type C1, gene-like 1) and IKZF1 (IKAROS family zinc ﬁnger 1), is
intriguing because elucidating the function of these variants could
identify novel therapeutic targets for asthma.
Third, the GSDMB (gasdermin B) locus on chromosome
17q12–21 is within an LD block that has been robustly associated
with asthma4–6,12,13; yet, the causal gene and its function are still
unclear. The SNPs discovered by GWAS that are associated with
asthma are also associated with the expression of both GSDMB
and its close neighbour ORMDL3 in white blood cells12,
peripheral blood mononuclear cells21, lymphoblastic cells
lines42, CD4þ T cells23,24 and lung tissue22, and it has been
assumed both that the causal SNPs at this locus are expression
quantitative trait loci for these genes and that one or both of these
genes are involved in asthma pathogenesis. Our study revealed
several lines of evidence of association with GSDMB and
extensive functional variation within this gene, including a
common missense mutation rs2305479 (c.G871A, p.G291R;
rs2305479) that is predicted to be ‘probably damaging’ by
PolyPhen-2. This common variant was identiﬁed in the previous
EVE meta-analysis of GWAS4 (P¼ 1.21 10 12 in the
combined sample) and is in strong LD with the GWAS-
identiﬁed SNP, but its potential as a causal candidate has not
previously been discussed. Our study suggests rs2305479 as a
good candidate for the causal variant at this important locus and
implicates GSDMB more directly in asthma risk. We identiﬁed a
second potential causal variant, a common SNP within a splicing
site in GSDMB (rs11078928; c.661-2A4G; transcript accession
NM_001165959). This SNP was previously shown to have a
genotype-dependent effect on GSDMB transcript levels, whereby
the asthma risk allele (A) was associated with increased
expression of an alternate transcript lacking exons 5–8 (ref. 43).
Although not much is known about the function of GSDMB or of
its alternative splice forms, other gasdermin genes are involved in
apoptosis in epithelial cells44, processes and cells that are relevant
to asthma. It is additionally notable that in contrast to GSDMB,
there was only one rare missense mutation in ORMDL3 in
Latinos (rs200735199, c457T, p.T96M; transcript accession
NP_644809; MAF 0.005) in the WGS from 278 asthmatics, and
this variant was not included on the exome array.
In summary, we report signiﬁcant associations of asthma with
rare or low-frequency variants in two novel genes, GRASP and
MTHFR, in Latinos and the African ancestry sample, respectively,
and with a potentially damaging common missense mutation in
GSDMB in Latinos and the combined sample. Based on the WGS
from 278 asthmatic subjects, our study included over 60% of all
putatively functional rare and low-frequency variation. Thus,
even if we discovered only half of all truly associated variants, it is
unlikely that rare and low-frequency variants will account for a
signiﬁcant portion of the heritability of asthma.
Methods
Study subjects. The subjects in the study were from 13 individual studies from
eight investigators that comprise the EVE Consortium on the Genetics of Asthma.
This sample has large overlap with our previous asthma meta-analyses4,10, but
includes three additional studies: GALA II, COAST and ALHS. Descriptions of
each of the studies can be found in prior published work4,10,11 or in Supplementary
Note 1. The results reported here are based on analyses of 4,794 asthma cases, 4,707
asthma controls and 590 case–parent trios (Table 1). All participants, or the
parents of minors, provided written informed consent. The relevant local
institutional research ethics committee approved each contributing study. Albert
Einstein College of Medicine of Yeshiva University, Baylor College of Medicine,
Brigham and Women’s Hospital, Children’s Memorial Hospital, Columbia
University, Henry Ford Health System, Johns Hopkins University, Kaiser
Permante, NIEHS (USA), National Institute of Public Health, Mexico (NIPH),
Northwestern University, San Juan VA Medical Center, University of California
San Francisco, University of Chicago, University of Southern California, University
of Wisconsin Madison, WIRB for Torre Medica Auxilio Mutuo.
Exome array. The Illlumina Inﬁnium HumanExome BeadChip genotyping array
interrogates 247,870 variants discovered from the exome and genome sequences of
B12,000 individuals of European American, African American, Latino and Asian
subjects from a range of common disorders. Variants included on the array are
predicted to have a functional effect on the protein and are enriched for missense
mutations, nonsense mutations and variants within predicted splice sites, as pre-
viously described30.
Genotyping. A total of 7,879 samples from 7 studies (CAG, CAMP, COAST,
GALA II, GRAAD, MCCAS and SAPPHIRE), including 107 blind duplicates, were
genotyped at the Northwest Genomics Center at the University of Washington. An
additional 2,440 CHS samples were genotyped at the Molecular Genomics Core at
the University of Southern California, using a different version of the array, and
1,585 ALHS samples were genotyped at the Center for Inherited Disease Research
at Johns Hopkins University. Genotype calling was performed using Genotyping
Module version 1.9.4, GenTrain version 1.0 in GenomeStudio version 2011.1 for all
projects, except for CHS that used GenTrain version 2.0. Genotype clustering was
deﬁned using our study samples and was completed independently for each
project.
Because of the different array design used for the CHS samples, the union of
239,909 (96.79%) variants was genotyped in the 13 sample sets. An additional 7,961
variants were genotyped in all the other samples and were subjected to quality
control and meta-analysed independent of CHS.
SNP quality control. Among the variants present on the Illumina HumanExome
BeadChip array, 244,794 (98.76%) passed quality control (Supplementary Table 5).
We excluded from analyses variants with genotype call rates o95%, Hardy–
Weinberg equilibrium P-values o10 4 in any of the studied populations (African
American, African Caribbean, European American and Mexican/Mexican American
or Puerto Rican) and 333 caution sites reported as problematic by the exome array
design group (http://genome.sph.umich.edu/wiki/Exome_Chip_Design). Among the
variants passing quality control, 197,339 (79.61%) were variable in the individuals
under study. In the combined sample, 23,206 (11.76%) variants were common
(MAFZ5%) to all ethnic groups, 36,413 (18.45%) were low-frequency (MAF 1–5%)
and 137,720 (69.79%) were rare (MAFo1%) in all three groups. Private variants for
each group and counts of variants tested are shown in Supplementary Table 1 and
Supplementary Table 2. Additional probe quality and genotype-calling evaluations
were performed and are described in Supplementary Note 2.
Sample quality control. Six hundred and seventy-nine subjects were excluded
from analysis (Supplementary Table 6), resulting in a ﬁnal sample size of 11,225
individuals. Sample exclusions included gender discordances, sample duplications,
Mendelian errors in trios, as implemented in PLINK45, missing case–control status
and incomplete trios. In addition, we completed principal component analysis
using the R function prcomp to identify ancestry outliers (Supplementary Figs 7–9).
Principal component analysis was carried out by using the ancestry informative
markers present on the exome array and including HapMap46 CEU, YRI, CHB,
JPT and MEX subjects. Fifty-six samples were excluded because one or both of the
ﬁrst two principle components were more than six s.d. from the mean of the
expected ethnic group. These inferred principle components were applied as
covariates in the gene-based tests.
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Single variant analyses. We subjected functional low-frequency variants to single
variant association analysis for each of the three ethnic groups (European Amer-
ican, African American and Latino) and for the combined sample. Low-frequency
variants (1–5%) were included in each of the ethnic-speciﬁc meta-analyses (8,249
in the European Americans, 17,861 in the African ancestry and 9,519 in the
Latinos) and the variants that were neither common (Z5%) in all 3 ethnic groups
nor rare (o1%) in all three ethnic groups (32,681 variants) were meta-analysed in
the combined sample (Supplementary Table 2). To control for population strati-
ﬁcation and relatedness, single SNP association tests for case–control studies were
completed using the linear mixed model GEMMA15. For the samples comprising
case–parent trios, we used the FBAT16. Z-score statistics obtained from GEMMA
and FBAT were combined in a meta-analysis as a weighted sum to reﬂect the
power of each independent study. The weight (w) used for each SNP is a function
of allele frequency (p), proportion of cases (v) and sample size (N)
ðw ¼ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃv 1 vð Þp 1 pð Þ2Np Þ10 of each study. P-values were calculated using
standard normal approximations and Bonferroni signiﬁcance thresholds were
applied (a¼ 0.05) to correct for the number of variants tested within each group
and in the combined sample. ORs were obtained for samples analysed with
GEMMA as a linear combination of log ORs with weights proportional to the s.e.
of the log ORs using the R package meta.
Power analyses for single-variant analyses. For each ethnic group and for the
combined sample, we performed the following simulations. We randomly selected
1,000 variants with MAF between 0.5% and 5%, and simulated genotypes 1,000
times for each of 5 ORs (OR¼ 1.5, 2, 2.5, 3 and 4). We used the same study
structure (sample sizes and case–control or parent offspring designs) and observed
MAF distributions that were present in our data. Z-scores were then meta-analysed
with the weighted approach described in the single-variant meta-analysis methods
and power was calculated with a predeﬁned a of 0.05. We plotted power estimates
versus MAF and implemented a local linear regression ﬁt with the R function loess
(Supplementary Fig. 2).
Gene-based analyses. Functional variants sets were deﬁned two ways: (1) mis-
sense, nonsense or variants within splice sites or (2) coding variants with Poly-
Phen-2 (ref. 29) prediction scoresZ0.957 (probably damaging variants). PolyPhen-
2 predicts possible impact of an amino acid substitution on the structure and
function of human proteins. In the ﬁrst functional deﬁnition set, variant pruning
for each gene was completed within each ethnic group by randomly selecting one
variant for each pair of functional variants with LD r240.9 (r2 and D’ values were
calculated with PLINK). Requiring each gene to comprise at least 3 functional
variants, we considered a total of 140,986 functional coding variants (8,933 genes)
in European Americans, 148,677 functional variants (10,342 genes) in African
Americans, 149,236 functional variants (10,439 genes) in Latinos and 151,006
functional variants (9,534 genes) in the combined sample. In the second functional
deﬁnition set, we considered a total of 20,077 functional coding variants (1,977
genes) in European Americans, 22,625 functional variants (2,465 genes) in African
Americans, 22,644 functional variants (2,427 genes) in Latinos and 22,248
functional variants (2,316 genes) in the combined sample. We performed a meta-
analysis of gene-based association tests applying the ﬁrst ﬁve principal components
as implemented in MetaSKAT-O28. Analyses were completed with two sets of
variant weights: either larger weights on rare variants (MetaSKAT-O default
parameter) or equal weights for all variants. Bonferroni signiﬁcance thresholds
were applied (a¼ 0.05) to correct for the number of genes tested within each group
and in the combined sample.
Assessment of functional variants on the Illumina exome array. WGS for the
278 asthmatics was carried out at Complete Genomics (CGI) and resulted in an
average read depth of 95.4% at 20 or greater across the exome target and 91.4%
across the genome. We excluded singletons from this analysis that were discovered
in the 278 WGS but not present in dbSNP137 or in the Exome Sequencing Project
variant server. We selected functional variants (missense, nonsense and splice site
mutations) that were of low-frequency or rare (MAF o5%) in any of the ethnic
groups in the WGS and identiﬁed the overlap with the variants present on the
exome array.
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